Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment Wei Long et al J. Med. Chem. 2024, 67, 13534−13549     This paper in the August addition has promoted a little bit of a SHP2 inhibitor profile – so more a suite of papers than a paper of the month... There are two